Crucell: Investors

Home | Contact | Search | Site Map

About Us

	Corporate Profile
	Share Information
	Financial Information
	Press Releases
	Event Calendar
	Presentations
	Shareholder Services
	Investor Relations Contact
	Crucell's press releases are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader. If you are new to RSS, we suggest you read the Introduction to RSS article.

Dutch German

2008 \| 2007 \| 2006 \| 2005 \| 2004 \| 2003 \| 2002 \| 2001 \| 2000

08 Dec 2003	Crucell Signs PER.C6(TM) Cell Line Development Service Agreement
21 Nov 2003	Crucell Presents Update on In-house Product Development Programs at Analyst Meeting
19 Nov 2003	Crucell Appoints Jean-Yves Guichoux, Executive Vice President, Development
17 Nov 2003	Crucell to Webcast Analyst Day on November 21st, 2003
14 Nov 2003	Crucell Presents Encouraging Results of its Malaria Vaccine Program
27 Oct 2003	Crucell Announces Resignation of M.A. de Haan
22 Oct 2003	Crucell Announces Malaria Vaccine Program in Collaboration with New York University, Walter Reed Army Institute of Research and GlaxoSmithKline
14 Oct 2003	Crucell and Gene Medicine Japan Initiate Manufacturing Partnership for Asia
13 Oct 2003	Crucell Announces Third Quarter 2003 Results
25 Sep 2003	Crucell and Novavax Announce PER.C6(TM) Vaccine Manufacturing Services
22 Sep 2003	Joint Crucell and Harvard Medical School Study Demonstrates the Potential of New Vaccine Delivery System for Diseases like HIV/AIDS
19 Sep 2003	Crucell - DSM Biologics Alliance to Present New PER.C6(TM) Data at Biophex Conference on September 25, 2003
19 Sep 2003	Crucell to Present at 2003 UBS Global Life Sciences Conference
03 Sep 2003	Crucell and Kimron Veterinary Institute Announce Anticipated Approval of West Nile Veterinary Vaccine Early 2004
28 Aug 2003	Crucell Hires Redington, Inc. to Expand its Reach and Raise Awareness in the US Investment Community
12 Aug 2003	Crucell and GeneMax Enter PER.C6(TM) License Agreement in Gene Delivery Field to Advance Clinical Trial
07 Aug 2003	Ebola Vaccine Holds Promise for Protection in Humans
14 Jul 2003	Crucell Announces Second Quarter 2003 Results
11 Jun 2003	Crucell is Developing West Nile Vaccine for Humans
11 Jun 2003	Crucell and Kimron Veterinary Institute Sign License Agreement for West Nile Veterinary Vaccine
03 Jun 2003	Crucell Expands Relationship with Merck & Co.
03 Jun 2003	Crucell and Merck & Co. Sign PER.C6(TM) Licensing Agreement for Therapeutic Protein Production
29 Apr 2003	Dr. C.E. Wilhelmsson and Mr. S. Lance nominated to Crucell's Supervisory Board
14 Apr 2003	Crucell publishes First Quarter 2003 Results
07 Apr 2003	Invitation Conference Call Q1 Results 2003
14 Feb 2003	Crucell Signs PER.C6(TM) License with Targeted Genetics
27 Jan 2003	Crucell and Aventis Pasteur Sign License Agreement for Manufacturing Viral Vaccines
27 Jan 2003	Crucell Reports 2002 Annual Results
16 Jan 2003	Crucell Signs PER.C6(TM) Antibody Production Agreement with Centocor